| Autosomal dominant polycystic kidney disease: core curriculum 2016 FT Chebib, VE Torres American Journal of Kidney Diseases 67 (5), 792-810, 2016 | 302 | 2016 |
| A practical guide for treatment of rapidly progressive ADPKD with tolvaptan FT Chebib, RD Perrone, AB Chapman, NK Dahl, PC Harris, M Mrug, ... Journal of the American Society of Nephrology 29 (10), 2458-2470, 2018 | 254 | 2018 |
| Vasopressin and disruption of calcium signalling in polycystic kidney disease FT Chebib, CR Sussman, X Wang, PC Harris, VE Torres Nature reviews Nephrology 11 (8), 451-464, 2015 | 141 | 2015 |
| Recent advances in the management of autosomal dominant polycystic kidney disease FT Chebib, VE Torres Clinical Journal of the American Society of Nephrology 13 (11), 1765-1776, 2018 | 108 | 2018 |
| Long-term administration of tolvaptan in autosomal dominant polycystic kidney disease ME Edwards, FT Chebib, MV Irazabal, TG Ofstie, LA Bungum, AJ Metzger, ... Clinical Journal of the American Society of Nephrology 13 (8), 1153-1161, 2018 | 91 | 2018 |
| Distinct and novel SLC26A4/Pendrin mutations in Chinese and U.S. patients with nonsyndromic hearing loss P Dai, AK Stewart, F Chebib, A Hsu, J Rozenfeld, D Huang, D Kang, V Lip, ... Physiological genomics 38 (3), 281-290, 2009 | 88 | 2009 |
| Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease. EZZM Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, Torres VE Nephrol Dial Transplant, 2016 | 80 | 2016 |
| Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy FT Chebib, VE Torres American Journal of Kidney Diseases 78 (2), 282-292, 2021 | 70 | 2021 |
| Presymptomatic screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease IM Sanchis, S Shukoor, MV Irazabal, CD Madsen, FT Chebib, MC Hogan, ... Clinical Journal of the American Society of Nephrology 14 (8), 1151-1160, 2019 | 65 | 2019 |
| Targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia S Suvakov, H Cubro, WM White, YS Butler Tobah, TL Weissgerber, ... Biology of sex differences 10, 1-13, 2019 | 64 | 2019 |
| Autosomal dominant polycystic kidney patients may be predisposed to various cardiomyopathies FT Chebib, MC Hogan, ZM El-Zoghby, MV Irazabal, SR Senum, ... Kidney international reports 2 (5), 913-923, 2017 | 62 | 2017 |
| The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD S Lavu, LE Vaughan, SR Senum, TL Kline, AB Chapman, RD Perrone, ... JCI insight 5 (15), 2020 | 60 | 2020 |
| Epidemiology of autosomal dominant polycystic kidney disease in Olmsted County T Suwabe, S Shukoor, AM Chamberlain, JM Killian, BF King, M Edwards, ... Clinical Journal of the American Society of Nephrology 15 (1), 69-79, 2020 | 58 | 2020 |
| Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease VT Huynh, MP Audrézet, JA Sayer, AC Ong, S Lefevre, V Le Brun, ... Kidney international 98 (2), 476-487, 2020 | 53 | 2020 |
| Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease FT Chebib, A Harmon, MVI Mira, YS Jung, ME Edwards, MC Hogan, ... Journal of the American College of Surgeons 223 (1), 118-126. e1, 2016 | 53 | 2016 |
| Intravitreal antivascular endothelial growth factor therapy may induce proteinuria and antibody mediated injury in renal allografts W Cheungpasitporn, FT Chebib, LD Cornell, ML Brodin, SH Nasr, ... Transplantation 99 (11), 2382-2386, 2015 | 51 | 2015 |
| Native Nephrectomy in Renal Transplant Recipients With Autosomal-Dominant Polycystic Kidney Disease MD Fouad T. Chebib, MD Mikel Prieto, MD Jung Yeonsoon, ... Transplantation Direct, 2015 | 46 | 2015 |
| The GPA-dependent, spherostomatocytosis mutant AE1 E758K induces GPA-independent, endogenous cation transport in amphibian oocytes AK Stewart, DH Vandorpe, JF Heneghan, F Chebib, K Stolpe, A Akhavein, ... American Journal of Physiology-Cell Physiology 298 (2), C283-C297, 2010 | 46 | 2010 |
| Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling CR Sussman, X Wang, FT Chebib, VE Torres Cellular signalling 72, 109649, 2020 | 43 | 2020 |
| The value of genetic testing in polycystic kidney diseases illustrated by a family with PKD2 and COL4A1 mutations E Cornec-Le Gall, FT Chebib, CD Madsen, SR Senum, CM Heyer, ... American Journal of Kidney Diseases 72 (2), 302-308, 2018 | 37 | 2018 |
